Global Summit on Bioavailability and Bioequivalence

The Global Summit on Bioavailability and Bioequivalence covers topics such as:

• BCS and BDDCS
• BCS and IVIVC Based Biowaivers
• Bioavailability and Bioequivalence
• Bio waivers based on BCS and IVIVC
• Clinical Pharmacology and Therapeutics
• Biosimilars and Biowaivers
• Drug Design and Development Challenges
• Clinical Research Vs Clinical Trails
• Factors Affecting Bioavailability
• Drug Metabolism and Drug Security
• Pharmaceutical Formulations
• Formulations and Modified Release Formulations
• Pharmacodynamic Endpoints for BE
• Pharmaceutical Metabolization
• Recent approaches to Biosimilars
• POPPK-PD and Pharmacometrics Applications to Assess BE
• Regulatory Science
• Recent biosimilars strategies
• Significance of BA/BE Studies
• Requirements for Regulatory Bioequivalence
• Trials in Clinical Pharmacology, Therapeutics, and Medicine